EUVIMEDEUVIMED entdecken
Crossref

Diagnostic sensitivity and specificity of INSM1 in pheochromocytomas versus adrenal cortical lesions

Douglas Jian-Xian Wu, Anandi Lobo, Jesse McKenney, Ankur R Sangoi

American Journal of Clinical Pathology · 05.05.2026 · 165 (5)

DOI: 10.1093/ajcp/aqag034 ↗

Kurz gefasst

Fachartikel in der Zeitschrift American Journal of Clinical Pathology, online erschienen am 07.05.2026. Verfasst von Douglas Jian-Xian Wu und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, Stanford Medical Center, Stanford, CA, United States. Hauptthemen laut MEDLINE: Pheochromocytoma, Adrenal Gland Neoplasms, Biomarkers, Tumor, Repressor Proteins. Die Arbeit nennt 39 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

While neuroendocrine markers such as chromogranin can be used to distinguish pheochromocytomas (positive) from adrenal cortical lesions (negative), other neuroendocrine markers such as synaptophysin can be positive in both entities. Insulinoma-associated protein 1 (INSM1) is a relatively novel marker often used in the diagnostic assessment of neuroendocrine tumors but with unexplored sensitivity/specificity in distinguishing between pheochromocytomas and adrenal cortical lesions.

Methods

Herein, semi-quantitative immunohistochemical expression for INSM1 was investigated in 35 pheochromocytomas and 64 adrenal cortical lesions (4 adrenal rests, 6 adrenal cortical hyperplasias, 43 adrenal cortical adenomas, 4 adrenal cortical neoplasms of uncertain malignant potential, 7 adrenal cortical carcinomas) and compared to relatively more traditional markers chromogranin and GATA3.

Results

INSM1 demonstrated diffuse strong nuclear staining in all pheochromocytomas (100%) and focal weak nuclear staining in rare adrenal cortical lesions (8%). Substratification showed INSM1 positivity in a subset of adrenal cortical hyperplasias (17%) and adrenal cortical adenomas (9%). For pheochromocytomas, overall sensitivity (and specificity compared to adrenal cortical lesions) was 100% (92%) for INSM1, 91% (97%) for GATA3, and 100% (100%) for chromogranin.

Conclusions

When attempting to distinguish pheochromocytomas from adrenal cortical lesions, INSM1 and GATA3 can be effective immunohistochemical tools with excellent sensitivity and specificity. However, while they may be helpful adjuncts in diagnostically challenging cases, chromogranin remains the gold-standard marker with even higher sensitivity and specificity.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PheochromocytomaAdrenal Gland NeoplasmsBiomarkers, TumorRepressor ProteinsAdrenal Cortex NeoplasmsAdrenocortical AdenomaHumansSensitivity and SpecificityImmunohistochemistryDiagnosis, DifferentialFemaleMaleGATA3 Transcription FactorMiddle AgedAdult

Stichwörter der Autor:innen

INSM1adrenal corticalpheochromocytomasensitivityspecificity

Substanzen

INSM1 protein, humanBiomarkers, TumorRepressor ProteinsGATA3 Transcription FactorGATA3 protein, human

Autor:innen und Institutionen

  • Department of Pathology, Stanford Medical Center, Stanford, CA, United States.
  • Department of Pathology, Kapoor Centre of Urology and Pathology, Raipur, India.
  • Department of Pathology, Cleveland Clinic, Cleveland, OH, United States.

Zitieren

APA

Wu, D. J., Lobo, A., McKenney, J., & Sangoi, A. R. (2026). Diagnostic sensitivity and specificity of INSM1 in pheochromocytomas versus adrenal cortical lesions. American Journal of Clinical Pathology, 165(5). https://doi.org/10.1093/ajcp/aqag034

Vancouver

Wu DJ, Lobo A, McKenney J, Sangoi AR. Diagnostic sensitivity and specificity of INSM1 in pheochromocytomas versus adrenal cortical lesions. American Journal of Clinical Pathology. 2026;165(5). doi:10.1093/ajcp/aqag034

BibTeX
@article{Wu2026,
  author = {Wu, Douglas Jian-Xian and Lobo, Anandi and McKenney, Jesse and Sangoi, Ankur R},
  title = {Diagnostic sensitivity and specificity of INSM1 in pheochromocytomas versus adrenal cortical lesions},
  journal = {American Journal of Clinical Pathology},
  year = {2026},
  volume = {165},
  number = {5},
  doi = {10.1093/ajcp/aqag034}
}
Kostenlos starten →